Condition: Vogt-Koyanagi-Harada Disease · Adalimumab · Sponsor: Tianjin Medical University
This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease
This description comes directly from the study's public registry record.
xiaomin zhang, M.D · +86-13920023990 · xiaomzh@126.com
Always discuss trial participation with your own doctor first.
| Tianjin Medical University Eye Hospital | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05590416